Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Clearside Biomedical, Inc. (CLSDQ) vs Notable Labs, Ltd. (NTBLQ)

Clearside Biomedical, Inc. and Notable Labs, Ltd. are both Biotechnology companies. Notable Labs, Ltd. is the larger, with a market value of $2.4M against $2.2M — 1.1× the size. Clearside Biomedical, Inc. grew revenue faster over the last twelve months: −56.8% against −129.0%. Notable Labs, Ltd. has the higher net margin (6,350.6% vs −780.9%) and the lower return on invested capital (−295.4% vs 0.00%). Across the 16 metrics below, Clearside Biomedical, Inc. leads on 8 and Notable Labs, Ltd. on 8.

Valuation

Metric CLSDQ NTBLQ Biotechnology median
P/E n/m n/m 7.88
P/S 0.39 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.25 0.74
EV/Sales 10.91 23.30 10.73
Earnings yield (2,075.24%) 0.00% (28.84%)
Free cash flow yield (1,661.90%) 0.00% (23.03%)

Profitability

Metric CLSDQ NTBLQ Biotechnology median
Gross margin 92.55% 116.87% 65.16%
Operating margin (689.76%) 9,259.04% 0.00%
Net margin (780.93%) 6,350.60% 0.00%
Free cash flow margin (653.23%) 9,158.43% 0.00%
Return on equity 58.59% (79.79%) (57.72%)
Return on assets (127.43%) (59.14%) (49.22%)
Return on invested capital 0.00% (295.36%) 0.00%

Growth

Metric CLSDQ NTBLQ Biotechnology median
Revenue growth (TTM) (56.78%) (129.02%) 5.64%
EPS growth (last fiscal year) 11.32% 84.47% —
Revenue growth, 5-year CAGR (5.20%) (11.93%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLSDQ NTBLQ Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 2.98 2.77 4.73
Net debt to EBITDA 0.69 0.80 0.96

Dividend

Metric CLSDQ NTBLQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLSDQ NTBLQ Biotechnology median
Market cap 2.15m 2.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack